Association of silicone breast implants with immunologic abnormalities: A prospective study

American Journal of Medicine

Volumn 106, Issue 1, 1999, Pages 11-19

  Karlson, Elizabeth W ^a,b   Hankinson, Susan E ^a   Liang, Matthew H ^a   Sanchez Guerrero, Jorge ^a   Colditz, Graham A ^a   Rosenau, Barbara J ^a   Speizer, Frank E ^a   Schur, Peter H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; COMPLEMENT; IMMUNOGLOBULIN; RHEUMATOID FACTOR; SILICON; THYROID ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BREAST ENDOPROSTHESIS; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; AUTOANTIBODIES; BREAST IMPLANTS; CONNECTIVE TISSUE DISEASES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; IMMUNE SYSTEM DISEASES; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; SILICONES;

EID: 0033055371     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00358-1     Document Type: Article

References (49)

1. Cook R.R., Delongchamp R.R., Woodbury M., Perkins L.L., Harrison M.C. The prevalence of women with breast implants in the United States - 1989. J Clin Epidemiol. 48:1995;519-525.
2. Terry M.B., Skovron M.L., Garbers S., Sonnenschein E., Toniolo P. The estimated frequency of cosmetic breast augmentation among US women, 1963 through 1988. Am J Public Health. 85:1995;1122-1124.
3. Sanchez-Guerrero J., Schur P.H., Sergent J.S., Liang M.H. Silicone breast implants and rheumatic disease. Clinical, immunologic, and epidemiologic studies. Arthr Rheum. 37:1994;158-168.
4. Bridges A.J., Vasey F.B. Silicone breast implants. History, safety, and potential complications. Arch Intern Med. 153:1993;2638-2644.
5. Gabriel S.E., Woods J.E., O'Fallon W.M., Beard C.M., Kurland L.T., Melton L.J. III. Complications leading to surgery after breast implantation. NEJM. 336:1997;677-682.
6. Weisman M.H., Vecchione T.R., Albert D., Moore L.T., Mueller M.R. Connective-tissue disease following breast augmentation a preliminary test of the human adjuvant disease hypothesis . Plast Reconstr Surg. 82:1988;626-630.
7. Dugowson C.E., Daling J., Koepsell T.D., Voyt L., Nellson S.L. Silicone breast implants and the risk of rheumatoid arthritis. Arthr Rheum. 35:1992;S66.
8. Schusterman M.A., Kroll S.S., Reece G.P., et al. Incidence of autoimmune disease in patients after breast reconstruction with silicone gel implants versus autogenous tissue a preliminary report . Ann Plast Surg. 31:1993;1-6.
9. Englert H.J., Brooks P. Scleroderma and augmentation mammoplasty - a causal relationship? Aust N Z J Med. 24:1994;74-80.
10. Gabriel S.E., O'Fallon W.M., Kurland L.T., Beard C.M., Woods J.E., Melton L.J. III. Risk of connective-tissue diseases and other disorders after breast implantation. NEJM. 330:1994;1697-1702.
11. Giltay E.J., Bernelot Moens H.J., Riley A.H., Tan R.G. Silicone breast prostheses and rheumatic symptoms a retrospective follow up study . Ann Rheum Dis. 53:1994;194-196.
12. Strom B.L., Reidenberg M.M., Freundlich B., Schinnar R. Breast silicone implants and risk of systemic lupus erythematosus. J Clin Epidemiol. 47:1994;1211-1214.
13. Wells K.E., Cruse C.W., Baker J.L. Jr, et al. The health status of women following cosmetic surgery. Plast Reconstr Surg. 93:1994;907-912.
14. Sanchez-Guerrero J., Colditz G.A., Karlson E.W., Hunter D.J., Speizer F.E., Liang M.H. Silicone breast implants and the risk of connective-tissue diseases and symptoms. NEJM. 332:1995;1666-1670.
15. Goldman J.A., Greenblatt J., Joines R., White L., Aylward B., Lamm S.H. Breast implants, rheumatoid arthritis, and connective tissue diseases in a clinical practice. J Clin Epidemiol. 48:1995;571-582.
16. Hochberg M.C., Perlmutter D.L., Medsger T.A. Jr, et al. Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma). Arthr Rheum. 39:1996;1125-1131.
17. Burns C.J., Laing T.J., Gillespie B.W., et al. The epidemiology of scleroderma among women assessment of risk from exposure to silicone and silica . J Rheumatol. 23:1996;1904-1911.
18. Hennekens C.H., Lee I.M., Cook N.R., et al. Self-reported breast implants and connective-tissue diseases in female health professionals. A retrospective cohort study. JAMA. 275:1996;616-621.
19. Silverman S., Bornstein D., Solomon G., Espinoza L., Colin M. Preliminary operational criteria for systemic silicone related disease (SSRD). Arthr Rheum. 39:1996;S51.
20. Williams H.J., Weisman M.H., Berry C.C. Breast implants in patients with differentiated and undifferentiated connective tissue disease. Arthr Rheum. 40:1997;437-440.
21. Marcus D.M. An analytical review of silicone immunology. Arthr Rheum. 39:1996;1619-1626.
22. Bridges A.J., Conley C., Wang G., Burns D.E., Vasey F.B. A clinical and immunologic evaluation of women with silicone breast implants and symptoms of rheumatic disease. Ann Intern Med. 118:1993;929-936.
23. Cuellar M.L., Scopelitis E., Tenenbaum S.A., et al. Serum antinuclear antibodies in women with silicone breast implants. J Rheumatol. 22:1995;236-240.
24. Press R.I., Peebles C.L., Kumagai Y., Ochs R.L., Tan E.M. Antinuclear autoantibodies in women with silicone breast implants. Lancet. 340:1992;1304-1307.
25. Claman H.N., Robertson A.D. Antinuclear antibodies and breast implants. West J Med. 160:1994;225-228.
26. Fisher J.C. The silicone controversy - when will science prevail? NEJM. 326:1992;1696-1698.
27. Karlson E.W., Sanchez-Guerrero J., Wright E.A., et al. A connective tissue disease screening questionnaire for population studies. Ann Epidemiol. 5:1995;297-302.
28. Sanchez-Guerrero J., Lew R.A., Fossel A.H., Schur P.H. Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus. Arthr Rheum. 39:1996;1055-1061.
29. Eaton R.B., Schnneider G., Schur P.H. Enzyme immunoassay for antibodies to native DNA. Specificity and quality of antibodies. Arthr Rheum. 26:1983;52-62.
30. Rosenau B., Schneebaun A.B., Schur P.H. The development of an ELISA method for the detection of "antibodies" to silicone. Curr Top Microbiol Immunol. 210:1996;69-74.
31. Ginsburg K.S., Liang M.H., Newcomer L., et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med. 117:1992;997-1002.
32. Falanga V., Medsger T.A. Jr, Reichlin M., Rodnan G.P. Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med. 104:1986;849-857.
33. Falanga V., Medsger T.A. Jr, Reichlin M. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Arch Dermatol. 123:1987;350-353.
34. Kulick K.B., Provost T.T., Reichlin M. Antibodies to single-stranded DNA in patients with discoid lupus erythematosus. Arthr Rheum. 25:1982;639-646.
35. Maddison P.J., Provost T.T., Reichlin M. Serological findings in patients with "ANA-negative" systemic lupus erythematosus. Medicine (Baltimore). 60:1981;87-94.
36. Schur P.H., Sandson J. Immunologic factors and clinical activity in systemic lupus erythematosus. NEJM. 278:1968;533-538.
37. Koffler D., Carr R., Agnello V., Thoburn R., Kunkel H.G. Antibodies to polynucleotides in human sera antigenic specificity and relation to disease . J Exp Med. 134:1971;294-312.
38. Carr R.I., Hoffman A.A., Harbeck R.J. Comparison of DNA binding in normal population, general hospital laboratory personnel, and personnel from laboratories studying SLE. J Rheumatol. 2:1975;178-185.
39. Sanchez-Guerrero J. Autoantibody testing in patients with silicone implants. N Am Clin Lab Med. 17:1997;341-353.
40. Bar-Meir E., Teuber S.S., Lin H.C., et al. Multiple autoantibodies in patients with silicone breast implants. J Autoimmun. 8:1995;267-277.
41. Keystone E., Peters W., Snow K., Rubin L., Smith D. Frequency of autoantibody detection in patients with silicone-gel implants. Arthr Rheum. 36:1993;S71.
42. Edworthy S.M., Martin L., Barr S., et al. A clinical study of the relationship between silicone breast implants and connective tissue disease. Arthr Rheum. 25:1998;254-260.
43. Cuellar M.L., Stem T.W. Jr, Espinoza L.R. Prevalence of antinuclear antibodies (ANAs) in women with silicone breast implants (SBI) clinical associations . Arthr Rheum. 37:1994;S270.
44. Zandman-Goddard G., Blank M., Ehrenfeld M., et al. Arthr Rheum. 39:1996;S51.
45. Goldblum R.M., Pelley R.P., O'Donell A.A., Pyron D., Heggers J.P. Antibodies to silicone elastomers and reactions to ventriculoperitoneal shunts [published erratum appears in Lancet 1992;340:800]. Lancet. 340:1992;510-513.
46. Wolf L.E., Lappe M., Peterson R.D., Ezrailson E.G. Human immune response to polydimethylsiloxane (silicone) screening studies in a breast implant population . FASEB J. 7:1993;1265-1268.
47. van Oss C.J., Naim J.O. Aspecific immunoglobulin binding to hydrophobic surfaces. Curr Top Microbiol Immunol. 210:1996;85-91.
48. Butler J.E., Lu E.P., Navarro P., Christiansen B. The adsorption of proteins on a polydimethylsiloxane elastomer (PEP) and their antigenic behavior. Curr Top Microbiol Immunol. 210:1996;75-84.
49. Tenenbaum S.A., Rice J.C., Espinoza L.R., et al. Use of antipolymer antibody assay in recipients of silicone breast implants. Lancet. 349:1997;449-454.